Roche Holding AG Says No Proof Tamiflu Resistance Rises

ZURICH, Nov 28 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research) on Tuesday said there had been no new evidence that resistance to its drug Tamiflu was on the rise, as governments move to deploy the treatment against avian influenza in humans.

>>> Discuss This Story

Back to news